Use of Telemedicine in Collaboration Between a Psychogeriatric Unit and Nursing Homes
Overview
The investigators want to evaluate the use of video-conference in the collaboration between the investigators psychogeriatric department and nursing homes. The study aim is to give supervision on a regular basis to the caregivers on a special care unit for patients with dementia with behavioural disturbances during a period of half a year. The investigators want to investigate the impact on caregivers and patients by applying certain tests at baseline, during the intervention and half a year after the intervention.
Full Title of Study: “Use of Telemedicine in Collaboration Between a Psychogeriatric Unit and Nursing”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Primary Purpose: Health Services Research
- Masking: None (Open Label)
- Study Primary Completion Date: September 2011
Interventions
- Behavioral: Training in person centered care by supervision using video-conference
- The investigators will use video-conference for supervising and training of staff members in nursing homes
Arms, Groups and Cohorts
- Experimental: Training and supervision of staff
- Staff members get training in person centered care by supervision using video-conference kit
Clinical Trial Outcome Measures
Primary Measures
- Neuropsychiatric inventory – nursing home version (NPI-NH)
- Time Frame: week 48
- The investigators want to find out if a supervision of staff members over a six months time, using video-conference technic, contributes to improvement in patients’ behaviour registered by NPI-NH
Secondary Measures
- Person-centered Care Assessment Tool (P-CAT) Person centered care assessment tool (P-CAT)
- Time Frame: week 48
- Measures the effect of our intervention related to apply person centred dementia care
Participating in This Clinical Trial
Inclusion Criteria
- Being resident in a special care unit for persons with dementia Exclusion Criteria:
- Shorter stay than four weeks before inclusion – terminally ill
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Sykehuset Innlandet HF
- Collaborator
- Norwegian Department of Health and Social Affairs
- Provider of Information About this Clinical Study
- Morten Lang-Ree, CEO, Sykehuset Innlandet Health Trust
- Overall Official(s)
- Oskar H Sommer, PhD, Principal Investigator, SykehusetInnlandet, Norway
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.